HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Craig A Elmets Selected Research

Skin Neoplasms (Skin Cancer)

2/2022Type I Interferons Enhance the Repair of Ultraviolet Radiation-Induced DNA Damage and Regulate Cutaneous Immune Suppression.
10/2021Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice.
1/2021IL-23 and the Tumor Microenvironment.
1/2018Tea polyphenols for the prevention of UVB-induced skin cancer.
10/2017Association of Vitamin D Receptor Polymorphisms With the Risk of Nonmelanoma Skin Cancer in Adults.
1/2015Vitamin D and skin cancer.
10/2014Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention.
2/2014Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway.
5/2013Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis.
1/2013Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Craig A Elmets Research Topics

Disease

62Neoplasms (Cancer)
02/2022 - 08/2003
21Skin Neoplasms (Skin Cancer)
02/2022 - 12/2005
20Carcinogenesis
10/2021 - 01/2005
17Psoriasis (Pustulosis Palmaris et Plantaris)
02/2021 - 11/2006
14Melanoma (Melanoma, Malignant)
01/2022 - 02/2007
12Inflammation (Inflammations)
10/2021 - 11/2009
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 12/2010
9Contact Dermatitis (Eczema, Contact)
01/2015 - 07/2006
5Basal Cell Carcinoma (Rodent Ulcer)
12/2017 - 06/2008
5Psoriatic Arthritis
02/2016 - 05/2008
5Carcinoma (Carcinomatosis)
05/2013 - 04/2006
3Nevus (Nevi)
01/2017 - 05/2014
3Residual Neoplasm
01/2017 - 08/2012
3Neoplasm Metastasis (Metastasis)
01/2016 - 12/2005
3Atopic Dermatitis (Atopic Eczema)
12/2014 - 07/2014
2Dysplastic Nevus Syndrome (Dysplastic Nevus)
01/2022 - 01/2021
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2018 - 01/2016
2Genomic Instability
11/2014 - 01/2011
2Keratosis
12/2011 - 06/2008
2Actinic Keratosis
12/2010 - 06/2008
2Sunburn
05/2006 - 04/2006
2Anthrax
09/2004 - 08/2004
1Bacterial Infections (Bacterial Infection)
01/2022
1Hidradenitis Suppurativa
01/2022
1Xeroderma Pigmentosum (Kaposi's Disease)
10/2021

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2004
12CytokinesIBA
01/2022 - 04/2007
9Interleukin-12 (IL 12)IBA
01/2021 - 04/2006
9Cadherins (E-Cadherin)IBA
01/2017 - 12/2008
8Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2005
8Interleukin-17 (Interleukin 17)IBA
01/2021 - 01/2008
7Biological ProductsIBA
04/2019 - 09/2005
6Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2015 - 12/2005
59,10-Dimethyl-1,2-benzanthraceneIBA
01/2021 - 01/2008
5InterleukinsIBA
01/2021 - 05/2007
5PhytochemicalsIBA
01/2018 - 01/2014
5VimentinIBA
01/2017 - 07/2011
5ArsenicIBA
10/2016 - 12/2011
5fisetinIBA
01/2016 - 07/2013
5Fibronectins (Fibronectin)IBA
01/2016 - 07/2011
4CarcinogensIBA
02/2022 - 11/2007
4PolyphenolsIBA
01/2018 - 12/2005
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2017 - 12/2005
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2016 - 01/2014
4HydrocarbonsIBA
05/2015 - 11/2007
4EnzymesIBA
10/2014 - 11/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 12/2005
4Cyclin D1IBA
02/2014 - 04/2007
4Matrix Metalloproteinases (MMPs)IBA
08/2012 - 12/2005
4Phosphotransferases (Kinase)IBA
08/2012 - 04/2011
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 09/2012
3Toll-Like Receptor 4IBA
10/2021 - 01/2008
3Interleukin-23 (Interleukin 23)IBA
01/2021 - 04/2007
3Pharmaceutical PreparationsIBA
01/2021 - 07/2011
3TeaIBA
01/2018 - 12/2005
3Calcitriol Receptors (Calcitriol Receptor)IBA
10/2017 - 05/2014
3VaccinesIBA
03/2015 - 08/2004
3Pyrimidine DimersIBA
03/2011 - 04/2006
3ProteomeIBA
12/2007 - 03/2005
2Messenger RNA (mRNA)IBA
10/2021 - 04/2007
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2021 - 01/2013
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2020 - 09/2009
2Thioguanine (Tioguanine)FDA Link
06/2020 - 09/2009
2Tacrolimus (Prograf)FDA LinkGeneric
06/2020 - 09/2009
2Leflunomide (Arava)FDA LinkGeneric
06/2020 - 09/2009
2Hydroxyurea (Hydrea)FDA LinkGeneric
06/2020 - 09/2009
2FumaratesIBA
06/2020 - 09/2009
2ErbB Receptors (EGF Receptor)IBA
02/2020 - 01/2013
2Photosensitizing Agents (Photosensitizers)IBA
09/2019 - 03/2008
2Interleukin-12 Subunit p35IBA
01/2017 - 04/2007
2Vitamin DFDA LinkGeneric
01/2017 - 01/2015
2anthraceneIBA
05/2016 - 03/2004
2Sorafenib (BAY 43-9006)FDA Link
01/2016 - 09/2015
2DNA (Deoxyribonucleic Acid)IBA
03/2015 - 06/2008
2Interleukin-17 ReceptorsIBA
01/2015 - 01/2012
2CollagenIBA
01/2015 - 01/2014
2delphinidinIBA
01/2015 - 01/2013
2Mitogen-Activated Protein KinasesIBA
11/2014 - 01/2014
2Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
08/2014 - 01/2010
2DinitrofluorobenzeneIBA
04/2013 - 01/2009
2Grape Seed ProanthocyanidinsIBA
03/2013 - 01/2005
2Caspase 3 (Caspase-3)IBA
01/2013 - 12/2005
2Metformin (Glucophage)FDA LinkGeneric
09/2012 - 04/2011
2Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2012 - 07/2011
2Drinking WaterIBA
12/2011 - 05/2007
2Sunscreening Agents (Sunscreens)IBA
03/2011 - 02/2007
2HaptensIBA
07/2009 - 09/2008
2EndotoxinsIBA
01/2008 - 07/2006
1Interferon Type IIBA
02/2022
1Keratins (Keratin)IBA
01/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
10/2021

Therapy/Procedure

20Therapeutics
02/2021 - 11/2006
7Chemoprevention
01/2022 - 08/2009
5Phototherapy (Light Therapy)
09/2019 - 03/2008
3Photochemotherapy (Photodynamic Therapy)
01/2010 - 03/2008
2Excimer Lasers
09/2019 - 01/2010
2Biological Therapy
07/2011 - 05/2008
2Oral Administration
05/2007 - 12/2005
1Complementary Therapies (Alternative Medicine)
02/2021